RE:Good DirectionHaving any size covid outbreak at a film shoot would be very costly as well as totally mess up film schedules, equipment rentals, etc, etc. It's not just the talent, there are an amazing amount of support staff associated with a shoot. Not to mention possible legal liabilities. So, this will be welcome and recurring revenue. I understand shareholder frustration with SCRN, they need to be more transparent with shareholders. But to flog SCRN on a public forum such as this is I think counter productive.
Why burn down your own house, so to speak? I'm in long, I believe this stock will fly if allowed to.
Patience is in short supply these days but I think the longs will be rewarded. I like that SCRN is not totally into covid testing and that they are trying to branch out into other revenue streams, hence
the aquisition of the biomedical company. I also like the fact that SCRN caught the attention of DM..
Let's see what plays out. Sometimes you have to roll the dice ( I kill me ) JMHO folks!